Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
19.45
+0.44 (2.31%)
At close: Oct 15, 2026, 4:00 PM EDT
19.47
+0.02 (0.10%)
After-hours: Oct 15, 2026, 7:45 PM EDT
Takeda Pharmaceutical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Takeda Pharmaceutical stock has a consensus rating of "Strong Buy" and an average price target of $22.77. The average 1-year stock price forecast is 17.07% higher than the current stock price, while the lowest is $21.06 (+8.28%) and the highest is $25.15 (+29.31%).
Price Target: $22.77 (+17.07%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Sep 14, 2026.
Analyst Ratings
The average analyst rating for Takeda Pharmaceutical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $43 | Buy | Maintains | $43 | +120.75% | Sep 14, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $21 | Buy | Maintains | $21 | +7.97% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
4.70T
from 4.51T
Increased by 4.40%
Revenue Next Year
4.80T
from 4.70T
Increased by 1.95%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.